DEF 14AThe Ballot
Aclaris Therapeutics, Inc. files DEF 14A
Filed Apr 21, 2017 · 9y ago · Accession 0001558370-17-002787
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Aclaris Therapeutics, Inc.
- Ticker
- ACRS
- CIK
- 1557746
- Form type
- DEF 14A
- Filing date
- Apr 21, 2017
- Report date
- Jun 15, 2017
- Document
- acrs-20170615xdef14a.htm
- Size
- 823 KB